CHD9 3'utr

CHD9 3'utr has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 26, 2026: “A regulatory RNA segment eases osteoporosis in mice”.

Intervention

1 paper studies it1 findingUpdated Oct 26, 2026

1 new paper in 30 daysSee all 1

1 lab

Animals1

What did studies of CHD9 3'utr find?

Studies of CHD9 3'utr measured 1 outcome; the most studied are postmenopausal osteoporosis (1 study).

Postmenopausal osteoporosis

downin mice1

1 study

CHD9 3'utr decreases postmenopausal osteoporosis in mice.
“In vivo experiments further demonstrated that the CHD9 3’UTR ameliorates ovariectomy-induced osteoporotic phenotypes.”
Animalsovariectomy-induced osteoporosis
A regulatory RNA segment eases osteoporosis in mice
Scientific reportsOct 26, 2026

Latest

1 paper in 12 months

Scientific ReportsOct 26

A regulatory RNA segment eases osteoporosis in mice

In an experiment in mice with their ovaries removed, the RNA segment eased physical features of osteoporosis.In an experiment in mice with their ovaries removed, the RNA segment eased physical features of osteoporosis.

Mouse studyBones and joints

Paper

CHD9 3'utr

What did studies of CHD9 3'utr find?

Latest

A regulatory RNA segment eases osteoporosis in mice

Related